• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于云最小二乘支持向量机的食管鳞状细胞癌新预后模型。

A new prognostic model of esophageal squamous cell carcinoma based on Cloud-least squares support vector machine.

作者信息

Liu Ke, Shen Liu-Qing, Zhang Dian-Bao, Kang Yi-Xin, Wang Yi-Xuan, Chen Pan, Zhang Ran, Gu Bian-Li, Jiao Ye-Lin, Yuan Xiang, Qi Yi-Jun, Gao She-Gan

机构信息

Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment, Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital (College of Clinical Medicine) of Henan University of Science and Technology, Luoyang, China.

School of Information Engineering, Henan University of Science and Technology, Luoyang, China.

出版信息

J Thorac Dis. 2023 Sep 28;15(9):4938-4948. doi: 10.21037/jtd-23-1058. Epub 2023 Sep 25.

DOI:10.21037/jtd-23-1058
PMID:37868877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10586994/
Abstract

BACKGROUND

In view of the low accuracy of the prognosis model of esophageal squamous cell carcinoma (ESCC), this study aimed to optimize the least squares support vector machine (LSSVM) algorithm to determine the uncertain prognostic factors using a Cloud model, and consequently, to establish a new high-precision prognosis model of ESCC.

METHODS

We studied 4,771 ESCC patients(training samples) from the Surveillance, Epidemiology, and End Results (SEER) database and 635 ESCC patients(validation samples) from the Henan Provincial Center for Disease Control and Prevention (HCDC) database, with the same exclusion criteria and inclusion criteria for both databases, and obtained permission to obtain a research data file in the SEER database from the National Cancer Institute. The independent risk factors were analyzed using the log-rank method, survival curves, univariate and multivariate Cox analysis. Finally, the independent prognostic factors were used to construct the nomogram, random forest and Cloud-LSSVM prognostic models were utilized for validation.

RESULTS

The overall median survival time of the SEER database was 14 months (HCDC samples was 46 months), the mean survival time was 26.5 months (HCDC samples was 36.8 months), and the 3-year survival rate was 65.8%. This is because most of the patients with Henan samples are early ESCC, and most of the Seer patients are T3 and T4 people. The multivariate Cox analysis showed that age at diagnosis (P<0.001), sex (P=0.001), race (P=0.002), differentiation grade (P<0.001), pathologic T category (P<0.001), and pathologic M category (P<0.001) were the factors affecting the prognosis of ESCC patients. The SEER data and HCDC database results showed that the accuracy of the Cloud-LSSVM (C-index =0.71, 0.689) model is higher than the differentiation grade (C-index =0.548, 0.506), random forest (C-index =0.649, 0.498), and nomogram (C-index =0.659, 0.563). This new model can realize the unity of the randomness and fuzziness of the Cloud model and utilize the powerful learning and non-linear mapping abilities of LSSVM.

CONCLUSIONS

Due to the difference of clans between training samples and test samples, the accuracy of prediction is generally not high, but the accuracy of Cloud-LSSVM model is much higher than other models. The new model provides a clear prognostic superiority over the random forest, nomogram, and other models.

摘要

背景

鉴于食管鳞状细胞癌(ESCC)预后模型的准确性较低,本研究旨在优化最小二乘支持向量机(LSSVM)算法,使用云模型确定不确定的预后因素,从而建立一种新的高精度ESCC预后模型。

方法

我们研究了来自监测、流行病学和最终结果(SEER)数据库的4771例ESCC患者(训练样本)以及来自河南省疾病预防控制中心(HCDC)数据库的635例ESCC患者(验证样本),两个数据库具有相同的排除标准和纳入标准,并获得了美国国立癌症研究所的许可以获取SEER数据库中的研究数据文件。使用对数秩检验、生存曲线、单因素和多因素Cox分析来分析独立危险因素。最后,使用独立预后因素构建列线图,利用随机森林和云-LSSVM预后模型进行验证。

结果

SEER数据库的总体中位生存时间为14个月(HCDC样本为46个月),平均生存时间为26.5个月(HCDC样本为36.8个月),3年生存率为65.8%。这是因为河南样本中的大多数患者为早期ESCC,而Seer患者中的大多数为T3和T4期患者。多因素Cox分析显示,诊断时年龄(P<0.001)、性别(P=0.001)、种族(P=0.002)、分化程度(P<0.001)、病理T分期(P<0.001)和病理M分期(P<0.001)是影响ESCC患者预后的因素。SEER数据和HCDC数据库结果表明,云-LSSVM(C指数=0.71,0.689)模型的准确性高于分化程度(C指数=0.548,0.506)、随机森林(C指数=0.649,0.498)和列线图(C指数=0.659,0.563)。这种新模型可以实现云模型随机性和模糊性的统一,并利用LSSVM强大的学习和非线性映射能力。

结论

由于训练样本和测试样本之间存在族群差异,预测准确性一般不高,但云-LSSVM模型的准确性远高于其他模型。新模型相对于随机森林、列线图和其他模型具有明显的预后优势。

相似文献

1
A new prognostic model of esophageal squamous cell carcinoma based on Cloud-least squares support vector machine.一种基于云最小二乘支持向量机的食管鳞状细胞癌新预后模型。
J Thorac Dis. 2023 Sep 28;15(9):4938-4948. doi: 10.21037/jtd-23-1058. Epub 2023 Sep 25.
2
Survival Risk Prediction of Esophageal Squamous Cell Carcinoma Based on BES-LSSVM.基于 BES-LSSVM 的食管鳞癌生存风险预测。
Comput Intell Neurosci. 2022 Jul 6;2022:3895590. doi: 10.1155/2022/3895590. eCollection 2022.
3
A survival prediction model based on PCA-HSIDA-LSSVM for patients with esophageal squamous cell carcinoma.基于 PCA-HSIDA-LSSVM 的食管鳞癌患者生存预测模型。
Proc Inst Mech Eng H. 2023 Dec;237(12):1409-1426. doi: 10.1177/09544119231205664. Epub 2023 Oct 25.
4
Comparison of clinicopathological features and survival analysis between esophageal neuroendocrine carcinoma and esophageal squamous cell carcinoma based on the SEER database, alongside nomogram analysis for esophageal neuroendocrine carcinoma.基于监测、流行病学和最终结果(SEER)数据库对食管神经内分泌癌和食管鳞状细胞癌的临床病理特征进行比较及生存分析,并对食管神经内分泌癌进行列线图分析。
J Gastrointest Oncol. 2023 Dec 31;14(6):2309-2323. doi: 10.21037/jgo-23-905. Epub 2023 Dec 22.
5
Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma.采用机器学习方法鉴定食管鳞癌的关键预后分子。
BMC Cancer. 2021 Aug 9;21(1):906. doi: 10.1186/s12885-021-08647-1.
6
The prognostic performance of the log odds of positive lymph nodes in patients with esophageal squamous cell carcinoma: A population study of the US SEER database and a Chinese single-institution cohort.食管鳞癌患者阳性淋巴结对数优势比的预后性能:美国 SEER 数据库的人群研究和中国单机构队列研究。
Cancer Med. 2021 Sep;10(17):6149-6164. doi: 10.1002/cam4.4120. Epub 2021 Jul 9.
7
Positive lymph node ratio is an important index to predict long-term survival for advanced esophageal squamous carcinoma patients (II∼III) with R0 resection--a SEER-based analysis.阳性淋巴结比例是预测接受R0切除的晚期食管鳞癌(II至III期)患者长期生存的重要指标——一项基于监测、流行病学和最终结果(SEER)数据库的分析
Heliyon. 2023 Nov 27;9(12):e22600. doi: 10.1016/j.heliyon.2023.e22600. eCollection 2023 Dec.
8
Focus on patients with early esophageal cancer-a prognostic nomogram.关注早期食管癌患者——一种预后列线图
Transl Cancer Res. 2020 Dec;9(12):7469-7478. doi: 10.21037/tcr-19-1645.
9
Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study.基于监测、流行病学和最终结果(SEER)数据库预测直肠鳞状细胞癌患者总生存期的列线图:一项基于人群的加强观察性研究报告(STROBE)队列研究
Medicine (Baltimore). 2019 Nov;98(46):e17916. doi: 10.1097/MD.0000000000017916.
10
Use of survival support vector machine combined with random survival forest to predict the survival of nasopharyngeal carcinoma patients.使用生存支持向量机结合随机生存森林预测鼻咽癌患者的生存情况。
Transl Cancer Res. 2023 Dec 31;12(12):3581-3590. doi: 10.21037/tcr-23-316. Epub 2023 Dec 21.

引用本文的文献

1
NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted cancer therapeutic route.NY-ESO-1特异性T细胞受体工程化T细胞与曲尼司特(一种TRPV2拮抗剂)的二价治疗增强了对食管癌的杀伤作用:一条双靶点癌症治疗途径。
Cancer Cell Int. 2024 Feb 9;24(1):64. doi: 10.1186/s12935-024-03249-w.

本文引用的文献

1
Selective activation of TGFβ signaling by -mediated upregulation of GARP aggravates esophageal squamous cell carcinoma.通过介导GARP上调实现的转化生长因子β(TGFβ)信号通路的选择性激活会加重食管鳞状细胞癌。
Am J Cancer Res. 2023 May 15;13(5):2013-2029. eCollection 2023.
2
A new risk score model based on lactate dehydrogenase for predicting prognosis in esophageal squamous cell carcinoma treated with chemoradiotherapy.一种基于乳酸脱氢酶的新风险评分模型,用于预测接受放化疗的食管鳞状细胞癌患者的预后。
J Thorac Dis. 2023 Apr 28;15(4):2116-2128. doi: 10.21037/jtd-23-388. Epub 2023 Apr 26.
3
Identification of Differentially Expressed Genes Related to the Lipid Metabolism of Esophageal Squamous Cell Carcinoma by Integrated Bioinformatics Analysis.
基于整合生物信息学分析鉴定食管鳞癌脂质代谢相关差异表达基因。
Curr Oncol. 2022 Dec 20;30(1):1-18. doi: 10.3390/curroncol30010001.
4
A narrative review on machine learning in diagnosis and prognosis prediction for tongue squamous cell carcinoma.关于机器学习在舌鳞状细胞癌诊断和预后预测中的叙述性综述。
Transl Cancer Res. 2022 Dec;11(12):4409-4415. doi: 10.21037/tcr-22-1669.
5
Pembrolizumab combined with paclitaxel and platinum as induction therapy for locally advanced esophageal squamous cell carcinoma: a retrospective, single-center, three-arm study.帕博利珠单抗联合紫杉醇和铂类作为局部晚期食管鳞状细胞癌的诱导治疗:一项回顾性、单中心、三臂研究。
J Gastrointest Oncol. 2022 Dec;13(6):2758-2768. doi: 10.21037/jgo-22-1196.
6
Curative Management After Endoscopic Resection for Esophageal Squamous Cell Carcinoma Invading Muscularis Mucosa or Shallow Submucosal Layer-Multicenter Real-World Survey in Japan.内镜切除治疗黏膜肌层或浅固有肌层浸润性食管鳞癌后的治疗管理-日本多中心真实世界调查。
Am J Gastroenterol. 2023 Jul 1;118(7):1175-1183. doi: 10.14309/ajg.0000000000002106. Epub 2022 Dec 24.
7
OPN Promotes Cell Proliferation and Invasion through NF-B in Human Esophageal Squamous Cell Carcinoma.OPN 通过 NF-B 促进人食管鳞癌细胞的增殖和侵袭。
Genet Res (Camb). 2022 Dec 15;2022:3154827. doi: 10.1155/2022/3154827. eCollection 2022.
8
Computational Drug Repurposing Approach to Identify Novel Inhibitors of ILK Protein for Treatment of Esophageal Squamous Cell Carcinoma.用于鉴定治疗食管鳞状细胞癌的新型整合素连接激酶(ILK)蛋白抑制剂的计算药物重定位方法
J Oncol. 2022 Dec 29;2022:3658334. doi: 10.1155/2022/3658334. eCollection 2022.
9
Multimodal Treatment Strategies to Improve the Prognosis of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: A Narrative Review.改善局部晚期胸段食管鳞状细胞癌预后的多模式治疗策略:一项叙述性综述
Cancers (Basel). 2022 Dec 20;15(1):10. doi: 10.3390/cancers15010010.
10
Prognostic Factors for Patients With Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery.新辅助化疗联合手术治疗后食管鳞癌患者的预后因素。
In Vivo. 2022 Nov-Dec;36(6):2852-2860. doi: 10.21873/invivo.13025.